Vertex Pharmaceuticals Inc / Ma

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

3,000,778

Value ($000)

1,360,433

Weight

0.3%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,360,433	0.3%	3,000,778	12/31/2025
2025 Q3	11/14/2025	1,130,711	0.2%	2,887,117	9/30/2025
2025 Q2	8/14/2025	1,365,639	0.3%	3,067,473	6/30/2025
2025 Q1	5/19/2025	1,240,885	0.3%	2,559,476	3/31/2025
2024 Q4	2/14/2025	937,976	0.2%	2,329,219	12/31/2024
2024 Q3	11/14/2024	1,135,478	0.3%	2,441,468	9/30/2024
2024 Q2	8/14/2024	1,211,326	0.3%	2,584,327	6/30/2024
2024 Q1	5/15/2024	1,022,474	0.4%	2,446,052	3/31/2024
2023 Q4	2/14/2024	1,057,875	0.4%	2,599,904	12/31/2023
2023 Q3	11/13/2023	964,561	0.4%	2,773,799	9/30/2023
2023 Q2	8/11/2023	885,892	0.4%	2,811,731	6/30/2023
2023 Q1	5/15/2023	885,892	0.4%	2,811,731	3/31/2023
2022 Q4	2/14/2023	845,957	0.4%	2,929,416	12/31/2022
2022 Q3	11/14/2022	914,568	0.5%	3,158,692	9/30/2022
2022 Q2	8/12/2022	879,837	0.5%	3,122,314	6/30/2022
2022 Q1	5/16/2022	819,273	0.4%	3,139,337	3/31/2022
2021 Q4	2/14/2022	771,725	0.3%	3,514,231	12/31/2021
2021 Q3	11/15/2021	500,428	0.2%	2,758,853	9/30/2021
2021 Q2	8/16/2021	494,325	0.2%	2,451,645	6/30/2021
2021 Q1	5/14/2021	444,719	0.2%	2,069,519	3/31/2021
2020 Q4	3/1/2021	493,281	0.2%	2,087,167	12/31/2020
2020 Q3	11/13/2020	439,213	0.2%	1,614,043	9/30/2020
2020 Q2	8/14/2020	451,011	0.3%	1,553,549	6/30/2020
2020 Q1	5/15/2020	333,921	0.2%	1,403,326	3/31/2020
2019 Q4	2/14/2020	297,079	0.2%	1,356,835	12/31/2019
2014 Q1	5/23/2014	96,904	0.1%	1,370,252	3/31/2014
2013 Q4	1/31/2014	88,616	0.1%	1,192,666	12/31/2013